Volpara Health Technologies Ltd., a global provider of software for the early detection of cancer, has announced it is partnering with Trees that Count in a new commitment to offset more carbon emissions. Image courtesy: Volpara Health
July 28, 2023 — Volpara Health Technologies Ltd., a global provider of software for the early detection of cancer, has announced it is partnering with Trees that Count in a new commitment to offset more carbon emissions. This environmental charity brings together business, community, and everyday New Zealand residents to plant millions of trees across the country, reported a company statement. The company is based in Wellington, New Zealand, and has an office in Seattle, WA.
The announcement reported that Volpara has already reduced its carbon emissions by 17.4% this year. The reduction largely came from less Scope Two indirect emissions that result from the consumption of purchased energy, such as electricity or heat. Additionally, Volpara has donated several hundred trees to be planted at the Waipoapoa Road Planting Project which is converting 40 acres of farmland in Hawke’s Bay into a native bush corridor. Volpara funding has helped with the planting over 300 native trees in New Zealand.
“Volpara believes that every company can do something to help reduce emissions, and I am delighted that our trees will help protect native birds in New Zealand,” said Kathryn Greene, Chief People Office at Volpara. Greene added, “We are proud to be able to live up to our promise to do good in the world, not just through our mission to save families from cancer but also through our betterment of the planet as a whole.”
Certified B Corporations like Volpara represent a growing for-profit business community that puts people and the planet first, noted the company statement. These companies must meet high standards of social and environmental performance, accountability, and transparency, and must utilize business practices that do right by their employees, customers, business partners, and investors – something the company noted has long been part of Volpara’s DNA.
The company’s AI-powered image analysis enables radiologists to quantify breast tissue with precision and helps technologists produce mammograms with optimal image quality, positioning, compression, and dose. According to the company statement, Volpara software streamlines operations and provides key performance insights that support continuous quality improvement, and is used in over 2,000 facilities by more than 5,600 technologists, impacting nearly 17 million patients globally. It helps providers conduct more than three million cancer risk assessments each year and can be deployed stand-alone or fully integrated with electronic health record systems, mammography reporting systems, imaging hardware, and genetic laboratories.
More information: www.volparahealth.com
July 28, 2026 
